BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30255696)

  • 1. The Obesity and the Risk of Breast Cancer among Pre and Postmenopausal Women.
    Gravena AAF; Romeiro Lopes TC; Demitto MO; Borghesan DHP; Dell’ Agnolo CM; Brischiliari SCR; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2429-2436. PubMed ID: 30255696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study.
    Brouckaert O; Van Asten K; Laenen A; Soubry A; Smeets A; Nevelstreen I; Vergote I; Wildiers H; Paridaens R; Van Limbergen E; Weltens C; Moerman P; Floris G; Neven P;
    Breast Cancer Res Treat; 2018 Feb; 168(1):189-196. PubMed ID: 29159760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers associated with breast cancer are associated with obesity.
    Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
    Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of breast cancer subtypes and body mass index.
    Petekkaya I; Sahin U; Gezgen G; Solak M; Yuce D; Dizdar O; Arslan C; Ayyildiz V; Altundag K
    Tumori; 2013; 99(2):129-33. PubMed ID: 23748802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan).
    Yoo K; Tajima K; Park S; Kang D; Kim S; Hirose K; Takeuchi T; Miura S
    Cancer Lett; 2001 Jun; 167(1):57-63. PubMed ID: 11323099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?
    Lubián López DM; Orihuela López F; García-Berbel Molina L; Boza Novo P; Pozuelo Solís E; Menor Almagro D; Comino Delgado R
    Gynecol Oncol; 2014 Apr; 133(1):56-62. PubMed ID: 24680592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between menopausal status and obesity in affecting breast cancer risk.
    Rose DP; Vona-Davis L
    Maturitas; 2010 May; 66(1):33-8. PubMed ID: 20181446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol consumption and breast cancer oestrogen and progesterone receptor status.
    Enger SM; Ross RK; Paganini-Hill A; Longnecker MP; Bernstein L
    Br J Cancer; 1999 Mar; 79(7-8):1308-14. PubMed ID: 10098777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
    Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
    Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in China.
    Li J; Huang Y; Zhang BN; Fan JH; Huang R; Zhang P; Wang SL; Zheng S; Zhang B; Yang HJ; Xie XM; Tang ZH; Li H; He JJ; Hsieh E; Qiao YL; Li JY
    PLoS One; 2014; 9(1):e87224. PubMed ID: 24489874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
    Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
    Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.
    Kakugawa Y; Tada H; Kawai M; Suzuki T; Nishino Y; Kanemura S; Ishida T; Ohuchi N; Minami Y
    Breast Cancer Res Treat; 2017 Feb; 162(1):115-125. PubMed ID: 28044214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study of lifetime light intensity physical activity and breast cancer risk.
    Kobayashi LC; Janssen I; Richardson H; Lai AS; Spinelli JJ; Aronson KJ
    Cancer Causes Control; 2014 Jan; 25(1):133-40. PubMed ID: 24158779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies.
    Chen GC; Chen SJ; Zhang R; Hidayat K; Qin JB; Zhang YS; Qin LQ
    Obes Rev; 2016 Nov; 17(11):1167-1177. PubMed ID: 27432212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between body mass index and immunohistochemical subtypes in breast cancer.
    Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.